AMPH vs WAT · P/E 12, rev $732.0M vs P/E 32, rev $1.65B
Amphastar P (AMPH) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported WAT revenue for 2026-07-04 was $1.65B. Net income was -$136.0M. Revenue was up 29.8% from 2026-04-04 to 2026-07-04. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the AMPH and WAT stock pages for the full models.
Not investment advice.